| P2093 | author name string | Yuan Chang | |
| | Rui Zhao | |
| | Yi Liu | |
| | Wei Niu | |
| | Xian-Qiang Wang | |
| | Pei-Long Lian | |
| | Zhi-Xin Meng | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells | Q24672387 |
| | Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization. | Q34333914 |
| | Endocan expression and relationship with survival in human non-small cell lung cancer | Q34555793 |
| | Comparative epidemiology of gastric cancer between Japan and China | Q35555740 |
| | Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis. | Q35943349 |
| | Cancer prevention: a global perspective | Q36002189 |
| | Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis | Q36868721 |
| | Targeting angiogenesis: progress with anti-VEGF treatment with large molecules | Q37563976 |
| | Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. | Q38322625 |
| | Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1α in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features | Q39285472 |
| | Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. | Q39608822 |
| | Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. | Q39716028 |
| | Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. | Q40158663 |
| | Vascular endocan is preferentially expressed in tumor endothelium | Q40234958 |
| | Decorin prevents metastatic spreading of breast cancer. | Q40462238 |
| | Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma | Q43183910 |
| | Endocan expression correlated with poor survival in human hepatocellular carcinoma | Q44125824 |
| | Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis | Q44657676 |
| | Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease | Q45415175 |
| | Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma. | Q48649719 |
| | Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. | Q54425814 |
| | Decorin suppresses tumor cell-mediated angiogenesis | Q61771867 |
| | Serum endocan levels as a marker of disease activity in patients with Behçet disease | Q86620487 |
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microvessel | Q6840468 |
| P304 | page(s) | 5422-5429 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer | |
| P478 | volume | 22 | |